AstraZeneca
Pharmaceuticals AstraZeneca is one of the world’s leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, the company provides a powerful range of products for six important areas of healthcare - gastrointestinal, cardiovascular, cancer, respiratory, neuroscience and infection. Headquartered in the UK, with R&D headquarters in Sweden and a strong presence in the key US market, AstraZeneca sells in over 100 countries, manufactures in 20 and has major research centers in six. The Company employs more than 58,000 people worldwide with 11,000 in the US alone. AstraZeneca recognized as having one of the best development pipelines in the industry and spends over $10 million each working day to maintain a flow of new medicines designed to meet patients’ needs. Worldwide sales in 2002 totaled $17.8 billion with $9.3 billion in the US. AstraZeneca is committed to building on this success, using its leading position in many important areas of medicine to make a difference to the lives of patients and the healthcare professionals who treat them. |
|
BioExec
Ventures, LLC BioExec Ventures, LLC is a unique partnership of industry-experienced executives devoted to the biotechnology sector and its future growth and prosperity. We provide business development services, US representation for international firms and interim executive management to biotechnology and pharmaceutical companies, with an emphasis on U.S. representation for international biotechnology firms. Our mission is to accelerate value creation for tomorrow's industry-leading products and companies through timely, world-class industry and management expertise. We have amassed a significant number of executive-level contacts in premier pharmaceutical and biotech companies as well as in investment banking, venture capital, consulting and other industry-support sectors. Penetrating the US market and building partnerships is a critical step in the growth trajectories of innovative life-science and biotech start-ups in Europe and across the globe. BioExec Ventures leverages this extensive contact list to provide executive-level services to international BioPharma firms that lack these connections in the US, or cannot afford the time that it takes to build them. As part of your team, we can provide complete US business development activities and interim management at a fraction of the cost for a full-time employee, and our broad network amplifies the investment. |
|
Fish
& Richardson P.C Fish & Richardson has one of the largest biotechnology practices in the country. The breadth of our technical expertise is unmatched, covering virtually all biotechnology-related areas. Most of the experts in the group hold Ph.D.'s in disciplines such as molecular biology, biochemistry, organic chemistry, immunology, and botany. The firm's biotechnology clients include corporations, small companies, universities, hospitals, individuals, and investment firms. Intellectual property: Our broad-based intellectual property services for biotechnology companies include patent portfolio planning and analysis, opinions—including freedom to use, infringement and validity, and patentability opinions—patent-related analysis of competitive and other third-party positions, and patent portfolio analysis in connection with financing, evaluation, and acquisition of technology. Fish & Richardson attorneys created and regularly teach a course on "Biotechnology: Patents, Licensing & FDA Practice," part of Professor Irving Kayton's Patent Resources Group advanced curriculum. Corporate: We provide biotechnology clients with legal advice for business strategy and structuring, drafting and negotiation of licensing agreements, and financing transactions. We are also experienced in mergers & acquisitions; because our corporate and securities lawyers work closely with our intellectual property lawyers, we have particular expertise in intellectual property “due diligence” in connection with mergers and acquisitions. We have handled a wide variety of securities offerings and can assist with virtually any type of business or employment agreement. Litigation: We have extensive experience litigating disputes involving all types of intellectual property rights, including biotechnology, pharmaceutical, and chemical patent infringement cases. |
|
Invest
Australia Invest Australia attracts productive foreign direct investment to Australia to support sustainable industry growth and development and, since its establishment in 1997, has helped companied invest an estimated A$13 billion. Invest Australia is currently working with companies on projects with potential investment in Australia of more than A$50 billion. Working in partnership with
business and all levels of government, Invest Australia offers investors
a comprehensive, free and totally confidential service at all stages
of their investment. We offer specialist advice on Australia’s industry capabilities and strengths in biotechnology and pharmaceuticals, can arrange site visits and assist investors to find the right joint venture partner in Australia. Leading a national approach to investment attraction and facilitation. Invest Australia can also help cut through red tape,streamline project approval processes and identify any relevant government industry assistance schemes and possible incentives. Put Invest Australia to work for you. For further information about Invest Australia’s services or more about investment opportunities in Australia visit our website www.investaustralia.gov.au or contact one of our offices in the USA: San Francisco: +1 415 243
2071 New York: +1 212 351 6570
|
|
Katan
Associates Katan is a globally based advisory services organization that provides a variety of integrated and interdisciplinary business and financial services to developing, knowledge-based growth and biotechnology companies. Our clients will share in the diversified operational, financial and strategic experiences that Katan’s senior management has gained in their various roles with numerous companies. We have a proven track record of adding significant value to formative-stage companies, providing management, financial, business development and strategic basis for a company’s growth and success. Katan assists in any of the following areas:
|
 |
Kirkpatrick
& Lockhart LLP Profile to follow shortly. www.kl.com |
 |